| Dr Siamak Bagheri, PHARMD | |
|
8737 Beverly Blvd, West Hollywood, CA 90048-1828 | |
| (310) 657-2881 | |
| Not Available |
| Full Name | Dr Siamak Bagheri |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 8737 Beverly Blvd, West Hollywood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114095643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 45786 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Siamak Bagheri, PHARMD 8737 Beverly Blvd, West Hollywood, CA 90048-1828 Ph: (310) 657-2881 | Dr Siamak Bagheri, PHARMD 8737 Beverly Blvd, West Hollywood, CA 90048-1828 Ph: (310) 657-2881 |
News Archive
Today, Shriners Hospitals For Children announced Leo Burnett Business, the business-to-business agency of The Leo Burnett Group, as its agency of record for all brand positioning, creative strategy, media and public relations initiatives.
Alcoholism is commonly associated with chronic smoking, and both alcohol and nicotine are believed to act on the same brain region. Research builds upon previous research that identified four potential alcohol-sensitive genes in the prefrontal cortex, finding that smoking also influences the expression of these genes.
Interferon-alpha (IFN) has been a mainstay in the systemic treatment of metastatic renal cell carcinoma (RCC) for decades, with response rates ranging from 3-15%.
A contact tracing study presented at this year's ESCMID Conference on Coronavirus Disease (ECCVID) confirms the effectiveness of wearing of masks in public, handwashing, and social distancing to protect against SARS-CoV-2 infection.
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
› Verified 9 days ago
Richard Ludwig Pilsl, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 834 Huntley Dr, West Hollywood, CA 90069 Phone: 619-204-8642 | |
Van Benjamin Hau, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8607 Santa Monica Blvd, West Hollywood, CA 90069 Phone: 626-524-2951 | |
Dr. Jesse Ryan Wisniewski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8700 Beverly Blvd, Room A903, West Hollywood, CA 90048 Phone: 310-423-5611 Fax: 310-423-0412 | |
Ms. Jill Kolin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7100 Santa Monica Blvd, West Hollywood, CA 90046 Phone: 323-603-0005 Fax: 323-603-0707 | |
Edward A Bubar, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8500 Melrose Ave, #109, West Hollywood, CA 90069 Phone: 310-358-2400 Fax: 310-358-2410 | |
Dr. Andrea Saenz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8605 Santa Monica Blvd, West Hollywood, CA 90069 Phone: 855-472-2548 |